ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 28, 2019.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on July 15, 2019, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Controlled substance | Drug code | Schedule |
---|---|---|
3-Fluoro-N-methylcathinone (3-FMC) | 1233 | I |
Cathinone | 1235 | I |
Methcathinone | 1237 | I |
4-Fluoro-N-methylcathinone (4-FMC) | 1238 | I |
Pentedrone (α-methylaminovalerophenone) | 1246 | I |
Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I |
4-Methyl-N-ethylcathinone (4-MEC) | 1249 | I |
Naphyrone | 1258 | I |
N-Ethylamphetamine | 1475 | I |
N,N-Dimethylamphetamine | 1480 | I |
Fenethylline | 1503 | I |
Aminorex | 1585 | I |
4-Methylaminorex (cis isomer) | 1590 | I |
Gamma Hydroxybutyric Acid | 2010 | I |
Methaqualone | 2565 | I |
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) | 6250 | I |
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) | 7008 | I |
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) | 7010 | I |
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | 7011 | I |
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) | 7012 | I |
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) | 7014 | I |
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) | 7019 | I |
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) | 7020 | I |
FUB-AMB, MMB- FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) | 7021 | I |
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) | 7023 | I |
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) | 7024 | I |
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) | 7025 | I |
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) | 7031 | I |
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) | 7032 | I |
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) | 7033 | I |
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) | 7034 | I |
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) | 7035 | I |
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) | 7036 | I |
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) | 7041 | I |
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) | 7042 | I |
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) | 7044 | I |
FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide) | 7047 | I |
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) | 7048 | I |
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) | 7049 | I |
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) | 7081 | I |
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) | 7083 | I |
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) | 7085 | I |
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) | 7089 | I |
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) | 7104 | I |
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) | 7118 | I |
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) | 7122 | I |
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 7144 | I |
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) | 7173 | I |
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) | 7200 | I |
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) | 7201 | I |
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) | 7203 | I |
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate | 7221 | I |
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) | 7222 | I |
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) | 7225 | I |
4-MEAP (4-Methyl-alpha-ethylaminopentiophenone) | 7245 | I |
N-Ethylhexedrone | 7246 | I |
Alpha-ethyltryptamine | 7249 | I |
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) | 7297 | I |
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) | 7298 | I |
Lysergic acid diethylamide | 7315 | I |
2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine | 7348 | I |
Marihuana | 7360 | I |
Tetrahydrocannabinols | 7370 | I |
Parahexyl | 7374 | I |
Mescaline | 7381 | I |
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) | 7385 | I |
3,4,5-Trimethoxyamphetamine | 7390 | I |
4-Bromo-2,5-dimethoxyamphetamine | 7391 | I |
4-Bromo-2,5-dimethoxyphenethylamine | 7392 | I |
4-Methyl-2,5-dimethoxyamphetamine | 7395 | I |
2,5-Dimethoxyamphetamine | 7396 | I |
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) | 7398 | I |
2,5-Dimethoxy-4-ethylamphetamine | 7399 | I |
3,4-Methylenedioxyamphetamine | 7400 | I |
5-Methoxy-3,4-methylenedioxyamphetamine | 7401 | I |
N-Hydroxy-3,4-methylenedioxyamphetamine | 7402 | I |
3,4-Methylenedioxy-N-ethylamphetamine | 7404 | I |
3,4-Methylenedioxymethamphetamine | 7405 | I |
4-Methoxyamphetamine | 7411 | I |
5-Methoxy-N-N-dimethyltryptamine | 7431 | I |
Alpha-methyltryptamine | 7432 | I |
Bufotenine | 7433 | I |
Diethyltryptamine | 7434 | I |
Dimethyltryptamine | 7435 | I |
Psilocybin | 7437 | I |
Psilocyn | 7438 | I |
5-Methoxy-N,N-diisopropyltryptamine | 7439 | I |
4'-Chloro-alpha-pyrrolidinovalerophenone | 7443 | I |
MPHP, 4'-Methyl-alpha-pyrrolidinohexiophenone | 7446 | I |
N-Ethyl-1-phenylcyclohexylamine | 7455 | I |
1-(1-Phenylcyclohexyl)pyrrolidine | 7458 | I |
1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I |
N-Benzylpiperazine | 7493 | I |
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) | 7498 | I |
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) | 7508 | I |
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) | 7509 | I |
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) | 7517 | I |
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) | 7518 | I |
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) | 7519 | I |
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) | 7521 | I |
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) | 7524 | I |
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) | 7532 | I |
MDPV (3,4-Methylenedioxypyrovalerone) | 7535 | I |
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7536 | I |
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7537 | I |
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7538 | I |
Methylone (3,4-Methylenedioxy-N-methylcathinone) | 7540 | I |
Butylone | 7541 | I |
Pentylone | 7542 | I |
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) | 7543 | I |
α-PHP, alpha-Pyrrolidinohexanophenone | 7544 | I |
alpha-pyrrolidinopentiophenone (α-PVP) | 7545 | I |
alpha-pyrrolidinobutiophenone (α-PBP) | 7546 | I |
PV8, alpha-Pyrrolidinoheptaphenone | 7548 | I |
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) | 7694 | I |
Acetyldihydrocodeine | 9051 | I |
Benzylmorphine | 9052 | I |
Codeine-N-oxide | 9053 | I |
Desomorphine | 9055 | I |
Codeine methylbromide | 9070 | I |
Dihydromorphine | 9145 | I |
Heroin | 9200 | I |
Hydromorphinol | 9301 | I |
Methyldesorphine | 9302 | I |
Methyldihydromorphine | 9304 | I |
Morphine methylbromide | 9305 | I |
Morphine methylsulfonate | 9306 | I |
Morphine-N-oxide | 9307 | I |
Normorphine | 9313 | I |
Pholcodine | 9314 | I |
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | 9547 | I |
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) | 9551 | I |
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) | 9560 | I |
Acetylmethadol | 9601 | I |
Allylprodine | 9602 | I |
Alphacetylmethadol except levo-alphacetylmethadol | 9603 | I |
Alphameprodine | 9604 | I |
Alphamethadol | 9605 | I |
Betacetylmethadol | 9607 | I |
Betameprodine | 9608 | I |
Betamethadol | 9609 | I |
Betaprodine | 9611 | I |
Dipipanone | 9622 | I |
Hydroxypethidine | 9627 | I |
Noracymethadol | 9633 | I |
Norlevorphanol | 9634 | I |
Normethadone | 9635 | I |
Trimeperidine | 9646 | I |
Phenomorphan | 9647 | I |
1-Methyl-4-phenyl-4-propionoxypiperidine | 9661 | I |
Tilidine | 9750 | I |
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) | 9811 | I |
Para-Fluorofentanyl | 9812 | I |
3-Methylfentanyl | 9813 | I |
Alpha-methylfentanyl | 9814 | I |
Acetyl-alpha-methylfentanyl | 9815 | I |
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide | 9816 | I |
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 | I |
Butyryl Fentanyl | 9822 | I |
Para-fluorobutyryl fentanyl | 9823 | I |
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9824 | I |
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide | 9825 | I |
Para-chloroisobutyryl fentanyl | 9826 | I |
Isobutyryl fentanyl | 9827 | I |
Beta-hydroxyfentanyl | 9830 | I |
Beta-hydroxy-3-methylfentanyl | 9831 | I |
Alpha-methylthiofentanyl | 9832 | I |
3-Methylthiofentanyl | 9833 | I |
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) | 9834 | I |
Thiofentanyl | 9835 | I |
Beta-hydroxythiofentanyl | 9836 | I |
Para-methoxybutyryl fentanyl | 9837 | I |
Ocfentanil | 9838 | I |
Valeryl fentanyl | 9840 | I |
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide | 9843 | I |
Cyclopropyl Fentanyl | 9845 | I |
Cyclopentyl fentanyl | 9847 | I |
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) | 9850 | I |
Amphetamine | 1100 | II |
Methamphetamine | 1105 | II |
Lisdexamfetamine | 1205 | II |
Phenmetrazine | 1631 | II |
Methylphenidate | 1724 | II |
Amobarbital | 2125 | II |
Pentobarbital | 2270 | II |
Secobarbital | 2315 | II |
Glutethimide | 2550 | II |
Nabilone | 7379 | II |
1-Phenylcyclohexylamine | 7460 | II |
Phencyclidine | 7471 | II |
ANPP (4-Anilino-N-phenethyl-4-piperidine) | 8333 | II |
1-Piperidinocyclohexanecarbonitrile | 8603 | II |
Alphaprodine | 9010 | II |
Cocaine | 9041 | II |
Codeine | 9050 | II |
Dihydrocodeine | 9120 | II |
Oxycodone | 9143 | II |
Hydromorphone | 9150 | II |
Diphenoxylate | 9170 | II |
Ecgonine | 9180 | II |
Ethylmorphine | 9190 | II |
Hydrocodone | 9193 | II |
Levomethorphan | 9210 | II |
Levorphanol | 9220 | II |
Isomethadone | 9226 | II |
Meperidine | 9230 | II |
Meperidine intermediate-A | 9232 | II |
Meperidine intermediate-B | 9233 | II |
Meperidine intermediate-C | 9234 | II |
Metazocine | 9240 | II |
Methadone | 9250 | II |
Methadone intermediate | 9254 | II |
Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
Morphine | 9300 | II |
Thebaine | 9333 | II |
Levo-alphacetylmethadol | 9648 | II |
Oxymorphone | 9652 | II |
Noroxymorphone | 9668 | II |
Thiafentanil | 9729 | II |
Racemethorphan | 9732 | II |
Alfentanil | 9737 | II |
Remifentanil | 9739 | II |
Sufentanil | 9740 | II |
Carfentanil | 9743 | II |
Tapentadol | 9780 | II |
Fentanyl | 9801 | II |
The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to its customers.
Dated: August 9, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18681 Filed 8-28-19; 8:45 am]
BILLING CODE 4410-09-P